MDSCs may contribute to IBD-initiated carcinogenesis by inhibiting cytotoxic T lymphocytes (CTLs), driving STAT3-dependent proliferation signals in intestinal epithelial cells (IECs), and inducing DNA damage by producing ROS [96]. Here, STAT3 is linked to inflammatory bowel disease.